Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Gregory

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|October 1, 1990
Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volumeW M Gregory, R H Reznek, M Hallett, et al.
British Journal of Cancer|January 1, 1997
Body weight and vascular invasion in post-menopausal women with breast cancerR A Badwe, I S Fentiman, R R Millis, et al.
Breast (Edinburgh, Scotland)|February 18, 2004
Applied kinesiology for treatment of women with mastalgiaW M Gregory, S P Mills, H H Hamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group studyH E Lambert, G J Rustin, W M Gregory, et al.
British Journal of Cancer|January 1, 1988
Who should measure quality of life, the doctor or the patient?M L Slevin, H Plant, D Lynch, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1986
Evaluating and designing cancer chemotherapy treatment using mathematical modelsB G Birkhead, W M Gregory, M L Slevin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group StudyH E Lambert, G J Rustin, W M Gregory, et al.
Cancer Research|February 15, 1991
A mathematical model relating response durations to amount of subclinical resistant diseaseW M Gregory, M A Richards, M L Slevin, et al.
The Journal of Pathology|August 1, 1995
Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markersL G Bobrow, L C Happerfield, W M Gregory, et al.
British Journal of Cancer|October 1, 1988
Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centresJ Wagstaff, W M Gregory, R Swindell, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|October 1, 1990
Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volumeW M Gregory, R H Reznek, M Hallett, et al.
British Journal of Cancer|January 1, 1997
Body weight and vascular invasion in post-menopausal women with breast cancerR A Badwe, I S Fentiman, R R Millis, et al.
Breast (Edinburgh, Scotland)|February 18, 2004
Applied kinesiology for treatment of women with mastalgiaW M Gregory, S P Mills, H H Hamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group studyH E Lambert, G J Rustin, W M Gregory, et al.
British Journal of Cancer|January 1, 1988
Who should measure quality of life, the doctor or the patient?M L Slevin, H Plant, D Lynch, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1986
Evaluating and designing cancer chemotherapy treatment using mathematical modelsB G Birkhead, W M Gregory, M L Slevin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1997
A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group StudyH E Lambert, G J Rustin, W M Gregory, et al.
Cancer Research|February 15, 1991
A mathematical model relating response durations to amount of subclinical resistant diseaseW M Gregory, M A Richards, M L Slevin, et al.
The Journal of Pathology|August 1, 1995
Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markersL G Bobrow, L C Happerfield, W M Gregory, et al.
British Journal of Cancer|October 1, 1988
Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centresJ Wagstaff, W M Gregory, R Swindell, et al.
Pageof 9